Previous Year Event Recaps


January 19, 2022
1:00 - 4:00 pm

Keynote Speaker:
Ann H. Partridge, MD, MPH
Professor of Medicine at Harvard Medical School
Vice Chair of Medical Oncology at Dana-Farber Cancer Institute Director of the Adult Survivorship Program


1:00 - 1:05 pm Introduction 
1:05 - 1:30 pm

Keynote Speaker:

Ann H. Partridge, MD, MPH
Professor of Medicine at Harvard Medical School
Vice Chair of Medical Oncology at Dana-Farber Cancer Institute Director of the Adult Survivorship Program  

Talk Title: "Improving Care and Outcomes for Young Women with Breast Cancer: From Observation to Intervention"

Biography: Hide Biography

Ann Partridge, MD, MPH is a Professor of Medicine at Harvard Medical School, and Vice Chair of Medical Oncology at Dana-Farber Cancer Institute, where she also serves as Director of the Adult Survivorship Program and leads the Program for Young Women with Breast Cancer. As a medical oncologist and clinical researcher, she has sought to improve the care and outcomes of patients with cancer by conducting research, and by developing innovative clinical programming.

Dr. Partridge serves in leadership roles nationally and internationally including as co-chair of the Breast Committee of the Alliance for Clinical Trials in Oncology and co-chair of the biennial ESMO-ESO sponsored Breast Cancer in Young Women Conference. She also served as Chair of the Center for Disease Control and Prevention (CDC) Advisory Committee on Breast Cancer in Young Women from 2010-17. She has received prior awards and grants including a Champions of Change award from the White House, an ASCO Improving Cancer Care Grant, the CDC Carol Friedman Award, the American Association for Cancer Research (AACR) Outstanding Investigator Award for Breast Cancer, and the Ellen L. Stovall Award in Cancer Survivorship from ASCO, and the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School.

After graduating from Georgetown University, Dr. Partridge received her medical degree from Cornell University Medical College, pursued an internal medicine residency at the Hospital for the University of Pennsylvania, and completed Medical Oncology and Hematology fellowship at Dana-Farber/Partners CancerCare. She earned a Master of Public Health degree at the Harvard School of Public Health.

1:30 - 2:00 pm

Panel Discussion

Tal Sella (
He received his medical degree from Tel Aviv University Sackler and with his medical oncology residency at Sheba Medical Center in Tel-HaShomer completed and a fellowship grant from APF, Dr. Tal Sella was accepted to the Advanced Fellowship program in breast oncology at the prestigious Dana-Farber Cancer Institute in Boston, MA.

Tamryn Gray ( 
Tamryn Gray is an Instructor in Medicine at Harvard Medical School within the Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute and the Department of Medicine (Division of Palliative Medicine) at BWH. She also holds joint roles as a research scientist within the Phyllis F. Cantor Center for Nursing and Patient Services Research and a clinical-administrative role as a Clinical Nurse Specialist in the Division of Stem Cell Transplantation and Cellular Therapies, Department of Medical Oncology at DFCI.

Peter Miller  (
Peter Miller grew up in Atlanta and moved to Cambridge after high school where he completed his undergraduate degrees in Chemical Engineering and Biology at the Massachusetts Institute of Technology. He completed his MD and PhD at Harvard Medical School where he studied leukemia stem cells in the laboratory of Gary Gilliland and Benjamin Ebert. After graduation, he completed an internal medicine residency at Brigham and Women's Hospital and fellowship in medical oncology at the Dana-Farber Cancer Institute / Massachusetts General Hospital combined program. His research focuses on the biology of myeloid malignancies and he is clinically part of the leukemia program at Dana-Farber Cancer Institute.

2:00 - 2:45 pm

Oral Presentations 

Breakout Room 1:

David Lee: Prevalence of monoclonal gammopathies, including an age-related monoclonal gammopathy of indeterminate potential (MGIP), and their associated risk factors and clinical outcomes: results of a screening study by mass spectrometry in a high-risk population

Sofia Vega: Expanding Bayesian Methods to Estimate Causal Effects of Environmental Exposures on Childhood Leukemia

Andrea Romanos-Nanclares: Insulinemic Potential of Diet and Risk of Total and Subtypes of Breast Cancer Among US Women

Pragya Kakani: The impact of physician-hospital integration on spending and quality of oncology care

Chaoran Ma: Association of Prostate Cancer Risk Variants with Gene Expression in Prostate Stroma

Phillip Nicol: pcDiffPop: Robust identification of perturbed cell types in single-cell RNA-seq data

Breakout Room 2:

Jim Doolin: A Phase II Feasibility Study of Electronic Patient Reported Outcomes (ePROs) for Oral Cancer Directed Therapies (OCDT)

Alexandra Bercow: NCCN Guideline-Discordant Care in Early-Stage Vulvar Cancer: A National Cancer Database Study

Kristen Brantley: A metabolomic analysis of adiposity measures and pre- and postmenopausal breast cancer risk in the Nurses’ Health Studies

Cheng Peng: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival

Bailey Vaselkiv: Intratumoral vitamin D signaling and lethal prostate cancer

Qiaoli Wang: Weight loss and subsequent cancer diagnosis: a prospective cohort study

2:45 - 3:30 pm

Poster Session   [Poster Booklet]

Khalid Alkhatib: Racial and Ethnic Disparities in High-Risk Cancer Genetic Testing Awareness in the United States; Health Information National Trends Survey (HINTS) Analysis [Poster] [Video]

Naiyu Chen: Impact of Age, Race, and Family History on COVID-19 Related Changes in Breast Cancer Screening and Diagnostic Imaging among the Boston Mammography Cohort Study [Poster] [Video]

Lydia Chevalier: Evaluating Sensitive Symptoms in Young Adult Cancer Survivors: Feasibility and Acceptability of Sexual Health and Suicide Items Across Administration Modes [Poster] [Video]

Cami Christopher: Improved insulin resistance and adiponectin among minority cancer survivors through circuit, interval-based exercise [Poster] [Video]

Krinio Giannikou: Distinct oncogenic signatures in malignant PEComa and leiomyosarcoma identified by integrative RNA-seq and H3K27ac ChIP-seq analysis [Poster] [Video]

Tian Gu: Synthetic data integration by leveraging external summary-level data to improve the risk prediction of prostate cancer [Poster] [Video]

Corinne Jansen: Does the histologic carcinoma subtype correlate with outcomes in uterine carcinosarcoma? [Poster][Video]

Dong-Woo Kang: Impacts of aerobic exercise on cardiorespiratory fitness and biochemical progression in men with prostate cancer on active surveillance: a randomized controlled trial [Poster] [Video]

Claire King: Inequities in referrals to a breast cancer personalized risk assessment and reduction program at an academic medical center [Poster] [Video]

Mara Koelker: Impact of exercise on physical health status in bladder cancer patients [Poster] [Video]

Muhieddine Labban: Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations [Poster] [Video]

Daniel Lage: CONTINUUM: A Pilot Care Transition Intervention for Hospitalized Patients with Advanced Cancer [Poster] [Video]

Colleen McGrath: Health Behaviors among Older Men and Cancer Survivors during the COVID-19 Pandemic [Poster] [Video]

Jennifer Mongiovi: Associations between intrauterine device and oral contraceptive use with ovarian cancer risk among 6 case-control studies from the Ovarian Cancer Association Consortium [Poster] [Video]

Eve Nagler: Scaling up tobacco control in India: Comparing smartphone to in-person training for implementing an evidence-based intervention to reduce tobacco use among schoolteachers: Study overview [Poster] [Video]

Kaitlin Nicholson: Patient-reported drivers of financial toxicity in gynecologic cancers: A focus group study [Poster] [Video]

Yuho Ono: Ampullary Neoplasia in Young Patients: Syndromic and non-syndromic associations [Poster] [Video]

Vineet Raghu: Validation of a deep learning-based model to estimate lung cancer risk from chest radiographs [Poster] [Video]

Takashi Shimizu: Associations of molecular characteristics with tumor-infiltrating lymphocytes in non-microsatellite instability-high colorectal cancer [Poster] [Video]

Alaina Shreves: Sleep problems among long-term prostate cancer survivors by metastatic disease status [Poster] [Video]

Tomotaka Ugai: Smoking and Colorectal Cancer Incidence by T cell, Macrophage, and Myeloid Cell Infiltrates in Cancer Tissue [Poster] [Video]

Rebekah Wilson: Impact of Exercise on the Complications of Corticosteroids in Patients with Graft-Versus-Host Disease following Allogeneic Stem Cell Transplantation: the RESTART Trial [Poster] [Video]

Yan Yan: Identifying strain-specific functional genes in colorectal cancer
[Poster] [Video]

Yin Zhang: Incident early- and later-onset type 2 diabetes and risk of early- and later-onset cancer [Poster] [Video]

3:30 pm Award Announcement

January 21, 2021
1:00 - 3:30 pm

Keynote Speaker:
Brian Wolpin, MD, MPH
Director, Gastrointestinal Cancer Center at Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School


1:00 - 1:05 pm Introduction 
1:05 - 1:30 pm

Keynote Speaker:

Brian Wolpin, MD, MPH
Director, Gastrointestinal Cancer Center at Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School 

Talk Title: "Multidisciplinary research to advance the care of patients with gastrointestinal cancers"

Dr. Wolpin received his medical degree from Harvard Medical School in 2001. He subsequently completed his residency in Internal Medicine at Brigham and Women's Hospital, and his fellowship in Medical Oncology at the Dana-Farber Cancer Institute.

He joined the staff of DFCI and Brigham and Women's Hospital in 2007, where he is a medical oncologist and clinical investigator in the Center for Gastrointestinal Oncology. His research focuses on biomarkers and novel therapeutics in gastrointestinal malignancies, with a particular focus on pancreatic cancer.

1:30 - 2:00 pm

Panel Discussion
Charlie Fuchs, Sapna Syngal. Matt Vander Heiden, and Kimmie Ng

2:00 - 2:45 pm Oral Presentations - Hide Presenters
  • Jan Heng: Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer
  • Bryan Iorgulescu: Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Patients with Advanced Colorectal Cancer
  • Jane Liang: Aggregating across genes and cancers in Mendelian risk prediction modeling
  • David-Dan Nguyen: Impact of the COVID-19 pandemic on the delivery of Definitive Therapy for Cancer at Mass General Brigham
  • Naoko Sasamoto: Personalized cutpoints of CA125 to improve early detection of ovarian cancer in postmenopausal women
  • Konrad Stopsack: Batch effects in tumor biomarker studies using tissue microarrays: Extent, impact, and remediation
  • Oana Zeleznik: Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women
2:45 - 3:30 pm

Poster Session - Hide Presenters

3:30 pm Award Announcement

November 4, 2019
9:00 - 1:00 pm

Plenary Speaker:
Irene M. Ghobrial, MD
Attending Physician, Medical Oncology, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
Director, Clinical Investigator Research Program, Dana-Farber Cancer Institute
Director, Michele & Stephen Kirsch Laboratory

2019 Award Winners


Best Oral Presentation:

Jennifer Spencer (HTCSPH)

Best Poster:

Jennifer Snaman (DFCI)



Most Promising Idea

Yuxi Liu (HTCSPH)


Smith 308 
1 Jimmy Fund Way,
Boston, MA 02215

Yawkey Conference Center
450 Brookline Ave,
Boston, MA 02215 


9:00 - 9:15 am Introduction (Smith 308)
9:15 - 10:00 am

Keynote Speaker:

Irene M. Ghobrial, MD
Attending Physician, Medical Oncology, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
Director, Clinical Investigator Research Program, Dana-Farber Cancer Institute
Director, Michele & Stephen Kirsch Laboratory

Dr. Ghobrial received her MD in 1995 from Cairo University School of Medicine, Egypt. She completed her Internal Medicine training at Wayne State University, Mich., and her Hematology/Oncology subspecialty training at Mayo Clinic College of Medicine, Minn. 

She joined Dana-Farber in the field of Waldenstrom's macroglobulinemia and multiple myeloma in 2005. She is conducting research in the area of homing and migration of B cells and novel therapeutic agents in Waldenstrom's macroglbulinemia and multiple myeloma.

10:00 - 10:15 am Q&A and Discussion
10:15 - 10:30 am Coffee Break
10:30 am - 11:45 pm Oral Presentations
12:00 - 12:45 pm Poster Session and Reception (Yawkey Conference Center)
12:45 - 1:00 pm Award Announcement

December 12, 2018
9:00 - 1:00 pm

Plenary Speaker:
Elena Martinez, PhD 
Associate Director, Population Science, Disparities and Community Engagement
Co-Leader, Community Outreach & Engagement Professor, Family Medicine and Public Health, University of California-San Diego

2018 Award Winners


Best Oral Presentation:

Emma McGee

Most Promising Idea

Jacqueline Seddon

Best Poster:

Karl Tully


Harvard Medical School, Waterhouse Room, Gordon Hall

9:00 - 9:15 am Introduction
9:15 - 10:00 am

Plenary talk by Elena Martinez, PhD
"Building the Next Generation of Cancer Disparities Scientists: We are Counting on You to Make a Difference!"

10:00 - 10:15 am Q&A and Discussion
10:15 - 10:30 am Coffee Break
10:30 am - 11:45 pm Oral Presentations
12:00 - 12:45 pm Poster Session and Reception 
12:45 - 1:00 pm Award Announcement 

Oral Presentations

Camila Lopes-Ramos - HSPH

Gene regulatory networks identify sex differences in colon cancer

Rachel Nethery - BWH

A causal inference framework for cancer cluster investigations with Bayesian estimation of causal standardized incidence ratios using publicly available data

Caleb Bae - DFCI

Variant-level BRCA mutations risk prediction model

Alessandra Ferrario - HMS

Trends in availability and use of cancer medicines in six Asian countries working towards universal health coverage

Kaelo Moahi - DFCI

Effect of HIV on Survival of Hodgkin Lymphoma: A Prospective Study in Botswana

Konrad Stopsack - HSPH

Single-cell multiplex immunofluorescence to identify PI3K pathway activation in archival prostate cancer tissue from two prospective cohort studies

Oana Zeleznik - BWH

Mammogram-derived texture features and risk of breast cancer

Emma McGee - BWH

Cigarette Smoking, Alcohol Consumption, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies

Kayoll Galbraith-Gyan - BWH

Community stakeholder and practitioner perspectives on introducing HPV and biobanking programming for underserved communities: A community engaged approach

Poster Presentations

Olga Ehrlich - DFCI

A Framework for Cancer Pain Social Processes and Poorly-Controlled Pain in the Hospice Caring Triad

Christina Nguyen - HMS

Oncology Care Delivery Systems

Allison Ringel - HMS

Immunomodulatory mechanisms in the tumor microenvironment

Xihao Hu - DFCI

Landscape of B cell immunity and related immune evasion in human cancers

Xia Xiang - HSPH

Circulating vitamin D and risk of breast and prostate cancer: a Mendelian randomization study

Marieke Krimphove - BWH

Variation and Correlation of Facility-level Probabilities of Treatment in Men with Low- risk Prostate Cancer and Men with Limited Life Expectancy

Lucia Petito - HSPH

Emulating randomized trials in SEER-Medicare: a causal approach

Yered Pita-Juarez - DFCI

Modeling the effect of copy number alterations in gene expression using matching normal tissues

Karl Tully - BWH

The effect of androgen deprivation therapy on the risk of cognitive-related conditions in men with prostate cancer: a population-based study

Yunqi Yang - HSPH

A Likelihood-based Approach to Assessing Frequency of Pathogenicity among Variants of Unknown Significance (VUS) in Susceptibility Genes

Zijie Zhao - DFCI

Revealing Transcriptional Variation of Chromosomal Abnormalities at Single-cell Level

Jaihwan Kim - DFCI

Clinical Factors Associated with Gastric Cancers among Lynch Syndrome Patients

Archana Agarwal - DFCI

Impact of pure versus mixed metastatic urothelial carcinoma (mUC) histology on response with immune checkpoint inhibitors (ICIs).

Abha Aggarwal - BWH

High Glucose Environment Increases Cell Proliferation and Hexokinase-2 Copy Number in Anaplastic Thyroid Cancer

Andres Korat - BWH

A prospective analysis of red blood cell trans fatty acid levels and risk of non-Hodgkin lymphoma

Ingabire Balinda - MGH

HIV infection not associated with decreased anal cancer survival

Kristen Brantley - HSPH

Plasma Estrogen Metabolites and Risk of Postmenopausal Breast Cancer in the Nurses’ Health Study

Vitoria De Carmo - BCH

Characterization of new regulators of S1PR1 endocytosis and signaling in endothelial cells

Barbra Dickerman - HSPH

Guideline-based physical activity and survival among US men with nonmetastatic prostate cancer

Chi Gao - HSPH

Validation of Breast Cancer Risk Prediction Models using Nurses Health and Nurse Health II Studies

Colby Hyland - HMS

The use of 18F-FDG PET/CT as an initial staging procedure for stage II-III breast cancer reduces false positives, costs, and time to treatment: a multicenter value analysis

Dong Hoon Lee - HSPH

Prediagnosis dietary pattern and survival in patients with multiple myeloma

Matthew Mossanen - BWH

Examining the impact of complications on perioperative mortality after radical cystectomy

Patricia Saade-Lemus - BIDMC

Characteristics of older adults with locally advanced and metastatic pancreatic ductal adenocarcinoma who do and do not receive palliative chemotherapy

Naoko Sasamoto - BWH

Breastfeeding patterns and ovarian cancer risk: Results from the Ovarian Cancer Association Consortium

Jacqueline Seddon - DFCI

Construction of pgRNA/CRISPR Cas9 Vectors for Validation of Synthetic Lethal Gene Interaction

Rui Song - HSPH

Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and Colorectal Cancer Survival: Results from Two Prospective Cohort Studies

Yiwen Zhang - HSPH

A prospective study of inflammation, focal atrophy, and lethal prostate cancer

Jill Ronacarati - HSPH

Housing Boston’s Rough Sleepers: outcomes from a 10-year prospective study

David Cote - HSPH

Tea, coffee, and caffeine intake and risk of glioma

November 6, 2017
1:00 - 6:00 pm







Paul Jacobsen
Associate Director of the National Cancer Institute Division of Cancer Control and Population Science’s Healthcare Delivery Research Program

2017 Award Winners


Best Oral Presentation:

Deirdre Tobias

Most Promising Idea

Khansa Sidahmed

Best Poster:

Barbra Dickerman


Yawkey Conference Center, Dana-Farber Cancer Institute
1:00 - 1:15 pm Introduction
1:15 - 2:15 pm Plenary talk by Paul Jacobsen: “Improving Cancer-Related Care and Outcomes: A Healthcare Delivery Research Agenda"
2:15 - 2:30 pm Coffee break
2:30 - 3:30 pm Short oral presentations
3:30 - 4:45 pm Poster Session
4:45 - 5:00 pm Award Ceremony and Closing Remarks by Dr. Giovanni Parmigiani

Oral Presentations

Erin Cook - HSPH

Effect of HPV Legislation to Increase Uptake of HPV Vaccination onTeen Sexual Behaviors

MK Downer - BWH

Moderate alcohol intake and risk of lethal prostate cancer in the Health Professionals Follow-up Study

Margaux Hujoel - Hsph

Estimating prevalence of rare genetic mutations

Catherine Marinac - DFCI

Elucidating under-studied aspects of the link between obesity and multiple myeloma: a prospective assessment of the influence of the stability, trajectory, and distribution of body fatness

Deirdre Tobias - BWH

Effect of randomized aspirin use in the Women’s Health Study on cancer incidence and mortality, by baseline inflammatory status

David Yang - HMS

Androgen Deprivation Therapy and Risk of Rheumatoid Arthritis in Patients with Prostate Cancer

Oana Zeleznik - BWH

Metabolomicanalysis of ovarian cancer riskinthe Nurses’ Health Studies: Identification of potentialnovel riskfactors of endometrioid/clear cell and mucinous tumors

Cindy Zhou - HSPH

Coffee consumption after prostate cancer diagnosis and survival among men in the Health Professionals Follow-up Study

Poster Presentations

Francisco Acevedo - MGH

Using Machine Learning and Natural Language Processing to Predict Cancer Risk after Multi-Gene Panel Testing

Justin Brown - DFCI

Muscle Wasting and Survival in Stage I-III Colorectal Cancer: A Population-Based Cohort Study (C-SCAN)

Daniela Buscariollo - BWH

Impact of pre-diagnosis depressive symptoms and quality of life on treatment choice for ductal carcinoma in situ in older women.

Barbra Dickerman - HSPH

Obesity and risk of prostate cancer

Hari Iyer - HSPH

Gender, cancer type, and treatment delay in Botswana

Robert Knoerl - DFCI

Efficacy of the Electronic Self-Report Assessment – Cancer (ESRA-C)

Melanie Kornides - HMS

A scale to measure parent satisfaction with provider communication about HPV vaccination: Psychometric properties and relationship to vaccination behaviors

Elizabeth Loehrer - HSPH

Serum 25-Hydroxyvitamin Dlevelsat diagnosis and overall survival in esophageal adenocarcinoma

Michael Milligan - DFCI

Imaging for Stage IA Non-Small Cell Lung Cancer (NSCLC)

Prasad Patil - DFCI

Incorporating Inter-Study Heterogeneity into the Training of Predictors

Joshua Petimar - HSPH

Recommendation-Based Dietary Indices and Risk of Colorectal Cancer in the Nurses’ Health Study and Health Professionals Follow-up Study

Naoko Sasamoto - BWH

CA125 ovarian cancer prediction models

Derek Shyer - DFCI

Simulation study to compare performance of dual-agent dose-escalation methods in a pediatric oncology framework

Khansa Sidhamed - HSPH

A Pooled Analysis of Dietary Fiber Intake and Prostate Cancer Risk

Cathy Wang - DFCI

Genetic factors for Lynch Syndrome and colorectal cancer risk

You Wu - HSPH

Dietary fiber and breast cancer risk

Jennifer Yland - HSPH

Dietary intake of folate, methionine, and vitamin B6 in relation to ovarian cancer survival in the New England Case-Control Study

Linying Zhang - HSPH

Interactions between multiple myeloma cells and bone marrow stromal cells impact epigenetic profiles of multiple myeloma

November 14, 2016
1:00 - 6:00 pm

Plenary Speaker:
Karen Emmons
Vice President for Research and Director,
Kaiser Foundation Research Institute

2016 Award Winners


Best Oral Presentation:

Kathryn Wilson

Most Promising Idea

Peter James

Best Poster:

Aymen Elfiki


Yawkey Conference Center, Dana-Farber Cancer Institute
2:00 - 2:05 pm Introduction
2:05 - 3:05 pm Plenary talk by Karen Emmons, PhD
“Realizing the Potential of Cancer Prevention in a Precision Era.”
3:05 - 3:20 pm Coffee break
3:20 - 4:45 pm Short oral presentations
4:45 - 5:00 pm Words from Dr. Laurie Glimcher, MD
5:00 - 6:00 pm Poster session (viewings, groups led by faculty, active discussions)
6:00 - 6:10 pm Closing Remarks by Dr. Frank Hu, MD
6:10 - 6:15 pm Award Announcement by Dr. Giovanni Parmigiani, PhD

Oral Presentations

Garcia de albeniz - HSPH

Colonoscopy and risk of infective endocarditis in the elderly

Peter James - HSPH

Light at night and breast cancer incidence in the Nurses' Health Study II

Loren Saulsberry - HMS

The impact of breast density notification laws on the use of supplemental breast cancer screening procedures

Helian Feng - HSPH/DFCI

A multi-tissue transcriptome-wide association study of breast cancer identifies 29 novel breast cancer susceptibility loci

Kathryn Wilson - HSPH

Baseline prostate-specific antigen (PSA) levels in midlife predict aggressive prostate cancer in African-American men

Salome Kuchukhidze - MGH

Knowledge and interest in lung cancer screening among community health center current and former smokers

Maud Fagny - DFCI/HSPH

A network-based approach to eQTL interpretation and SNP functional characterization

Catherine marinac - HSPH

Associations between timing of meals, physical activity, light exposure, and sleep with body mass index in free-living adults

Maxine Sun - BWH

Cognitive impairment after androgen deprivation therapy for advanced prostate cancer: a retrospective analysis and a pooled-analysis

Thomas Madsen - DFCI

Peeling and paring: an algorithm for computing carrier probabilities for an arbitrary number

Mesfin Bekalu - DFCI/HSPH

Emotional and cognitive reactions to tobacco graphic health warnings (GHWs) and associated quit attempts among low socioeconomic position (SEP) populations

Poster Presentations

David Cheng - HSPH

Inverse probability weighting with a responseinformed calibrated propensity score: a robust and efficient approach for treatment effects in large observational studies

Claire Kim - BWH

Stability and reproducibility of proteomic profiles measured with SOMAscan platform

Anupriya Dutta - DFCI

Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study

Peter James - HSPH

GPS-based exposure to greenness and objectively measured physical activity

Prasanna Ananth - DF/BCC and Blood Disorders Center

Providers perspectives on use of medical marijuana in pediatric oncology patients

Anish Mehta - BWH

Mediators of disparities in survival among patients with non-small cell lung cancer

Xia Jiang - HSPH

Analysis of shared heritability and functional enrichment based on genome-wide association studies for five common cancers

Trang VoPham - HSPH

Environmental radon and breast cancer risk in the Nurses’ Health Study II

Dana Footer - DF/BCC and Blood Disorders Center

Pain in survivors of pediatric brain tumors

Claire Pernar - HSPH

Physical activity and risk of prostate cancer defined by TMPRSS2:ERG

Ericka Ebot - HSPH

Gene expression profiling of prostate tissue identifies biological pathways associated with TMPRSS2:ERG gene fusion

Sarah Markt - HSPH

Age ≥ 40 years is associated with adverse outcomes in metastatic germ cell cancer despite appropriate intended chemotherapy

Aymen Elfiky - DFCI

Short-term mortality prediction using a machine learning algorithm for patients initiating chemotherapy

Giselle Perez-Lougee - MGH

Promoting resiliency among palliative care clinicians: stressors, coping strategies, and training needs

Giselle Perez-Lougee - MGH

Mental health insurance preferences, coverage and utilization among childhood cancer survivors

Zoe Guan - DFCI/HSPH

BRCA-Gail: a combination model for breast cancer risk prediction

Theo Huang - DFCI/HSPH

Using frailty models to improve familial cancer risk prediction

Jiabei Yang - DFCI/HSPH

A tool to predict cancer risk with uncommon genetic mutations

Shoshana Rosenberg - DFCI

Employment trends in young women following a breast cancer diagnosis

Maxine Chen CDNM—BWH/HMS

Transcriptome-wide association study of prostate cancer risk.

Joseph Paulson - DFCI/HSPH

Tissue-aware RNA-Seq processing and normalization for heterogeneous and sparse data

Marieke Kuijjer - DFCI

Modeling the effects of gene regulation on glioblastoma survival using individual patient networks

Camila Lopes-Ramos - DFCI

Sexual dimorphism in colon cancer revealed by gene regulatory networks

Evan Busch - BWH/HMS/HSPH

Mutations in genes related to epithelialmesenchymal transition in carcinomas

Candice Chow - DFCI

Relapse as a risk factor for anxiety in adolescent and young adult survivors of pediatric brain tumors

Mary Kathryn Downer - HSPH

Aspirin use and the risk of lethal prostate cancer in the Physicians' Health Study

Kevin Kensler - HSPH

Androgen receptor expression and breast cancer survival in the Nurses’ Health Study cohorts

Megan Rice - MGH/HMS

Texture variation on a mammogram and risk of breast cancer

Natalie DuPre - HSPH

Particulate matter exposures in relation to breast cancer survival

Ilaria Domenicano - DFCI

A Bayesian information-driven phase I/II dose-finding design

Mollie Barnard - HSPH

Analgesic use and risk of ovarian cancer in the Nurses’ Health Studies

Sarah Mantwill - DFCI

Interpersonal communication about graphic health warning labels in a vulnerable population – Predictors and smoking-related consequences of conversations